Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

C-reactive protein, an inflammatory biomarker, predicts progression of aortic valve stenosis

01.09.2003


ESC Congress 2003



Aortic stenosis (AS) is the narrowing or obstruction of the heart´s aortic valve, which prevents it from opening properly and blocks the flow of blood from the left ventricle to the aorta. AS is common in the ageing population and has become the most frequent native valve disease in Europe. AS when severe, may cause left heart failure, fainting or angina, but the natural progression of less severe degrees is highly variable.

The risk factors for the development of AS are the same as that of atherosclerosis (male sex, smoking, hypertension, age, hypercholesterolemia, and diabetes), and some of these seem to have an effect on AS progression as well. Numerous studies have identified inflammation as a major component of atherosclerosis complications and have shown that blood levels of C-reactive protein are elevated many years before a first heart attack or stroke occurs. C-reactive protein is a protein in the body whose level increases when blood vessels become inflamed, so measuring cardiovascular risk is thought to be possible by assessing C-reactive protein levels.


Accordingly, to these data, we have studied the possible association between inflammation, as detected by C-reactive protein levels, and progression of AS.

Our study was carried out in Salamanca, Spain. We looked at 43 patients with AS. We performed an echocardiogram and measured the blood levels of C-reactive protein at the beginning of the study, and we saw that patients with higher levels of C-reactive protein had more rapid progression of AS than patients with lower levels, when we repeat the echocardiogram six months later.

The mechanism of this is still under investigation, but raises the possibility that AS and atherosclerosis may share common pathophysiology pathways. Ability to predict AS progression has clinical implications in patients with AS, and could help in the selection of patients who are likely to benefit from early aortic valve replacement.

Pedro L Sanchez
University Hospital, Salamanca, Spain

IMPORTANT: This press release accompanies a poster or oral session given at the ESC Congress 2003. Written by the investigator himself/herself, this press release does not necessarily reflect the opinion of the European Society of Cardiology

Camilla Dormer | alfa
Further information:
http://www.escardio.org/vpo

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: First diode for magnetic fields

Innsbruck quantum physicists have constructed a diode for magnetic fields and then tested it in the laboratory. The device, developed by the research groups led by the theorist Oriol Romero-Isart and the experimental physicist Gerhard Kirchmair, could open up a number of new applications.

Electric diodes are essential electronic components that conduct electricity in one direction but prevent conduction in the opposite one. They are found at the...

Im Focus: Nonstop Tranport of Cargo in Nanomachines

Max Planck researchers revel the nano-structure of molecular trains and the reason for smooth transport in cellular antennas.

Moving around, sensing the extracellular environment, and signaling to other cells are important for a cell to function properly. Responsible for those tasks...

Im Focus: UNH scientists help provide first-ever views of elusive energy explosion

Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.

Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Optical Coherence Tomography: German-Japanese Research Alliance hosted Medical Imaging Conference

19.11.2018 | Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

 
Latest News

Helping to Transport Proteins Inside the Cell

21.11.2018 | Life Sciences

Meta-surface corrects for chromatic aberrations across all kinds of lenses

21.11.2018 | Power and Electrical Engineering

Removing toxic mercury from contaminated water

21.11.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>